---
figid: PMC8307595__diagnostics-11-01195-g003
figtitle: 'Impact of Endoscopic Ultrasound-Guided Tissue Acquisition on Decision-Making
  in Precision Medicine for Pancreatic Cancer: Beyond Diagnosis'
organisms:
- Homo sapiens
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC8307595
filename: diagnostics-11-01195-g003.jpg
figlink: /pmc/articles/PMC8307595/figure/diagnostics-11-01195-f003/
number: F3
caption: TRK pathway and mechanism of TRK inhibitors. The activation of TRK receptors
  (TRKA, TRKB, and TRKC) by the binding of the ligand neurotrophin promotes cell survival,
  proliferation, and differentiation through downstream PLCγ, MAPK, and PI3K pathways.
  Functional TRK-fusion proteins induce the ligand-independent activation of the tyrosine
  kinase domain to upregulate downstream cancer-related pathways. TRK inhibitors are
  tyrosine kinase inhibitors of TRK receptors and inhibit cancer-cell survival and
  proliferation by suppressing the MAPK pathway.
papertitle: 'Impact of Endoscopic Ultrasound-Guided Tissue Acquisition on Decision-Making
  in Precision Medicine for Pancreatic Cancer: Beyond Diagnosis.'
reftext: Hiroshi Imaoka, et al. Diagnostics (Basel). 2021 Jul;11(7):1195.
year: '2021'
doi: 10.3390/diagnostics11071195
journal_title: Diagnostics
journal_nlm_ta: Diagnostics (Basel)
publisher_name: MDPI
keywords: endoscopic ultrasound-guided tissue acquisition | endoscopic ultrasound-guided
  fine needle aspiration | endoscopic ultrasound-guided fine needle biopsy | next-generation
  sequencing | precision medicine | pancreatic cancer | chemotherapy | biomarker |
  targeted genome sequencing
automl_pathway: 0.931941
figid_alias: PMC8307595__F3
figtype: Figure
redirect_from: /figures/PMC8307595__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8307595__diagnostics-11-01195-g003.html
  '@type': Dataset
  description: TRK pathway and mechanism of TRK inhibitors. The activation of TRK
    receptors (TRKA, TRKB, and TRKC) by the binding of the ligand neurotrophin promotes
    cell survival, proliferation, and differentiation through downstream PLCγ, MAPK,
    and PI3K pathways. Functional TRK-fusion proteins induce the ligand-independent
    activation of the tyrosine kinase domain to upregulate downstream cancer-related
    pathways. TRK inhibitors are tyrosine kinase inhibitors of TRK receptors and inhibit
    cancer-cell survival and proliferation by suppressing the MAPK pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - NTRK1
  - TPM3
  - SHC1
  - SHC2
  - SHC3
  - SHC4
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - XYLT2
  - SOS1
  - SOS2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - GRB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDK2
  - PDK3
  - PDK4
  - AKT1
  - AKT2
  - AKT3
  - norpA
  - sl
  - Plc21C
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - trk
  - Shc
  - MKP-4
  - p38b
  - rl
  - Sos
  - ras
  - Ras64B
  - Ras85D
  - Raf
  - Dsor1
  - Mtk
  - drk
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Pdk
  - Pdk1
  - Akt
---
